IMMU-18. IMMUNOGENOMIC RESPONDER PHENOTYPE FROM A PHASE I...

IMMU-18. IMMUNOGENOMIC RESPONDER PHENOTYPE FROM A PHASE I TRIAL OF ANTI-LAG3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM

Jackson, Christina, Choi, John, Zhang, JiaJia, Piotrowski, Anna, Walbert, Tobias, Desai, Arati, Ahluwalia, Manmeet, Nabors, Burt, Ye, Xiaobu, Desideri, Serena, Fisher, Joy, Wen, Patrick, Grossman, Stu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noz175.511
Date:
November, 2019
File:
PDF, 88 KB
2019
Conversion to is in progress
Conversion to is failed